Canine babesiosis

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 20, Issue 4, 1998, Pages 418-430

  Lobetti, Remo G ^a,b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Europ Coll of Vet Int Medicine   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACARI; CANIDAE;

EID: 3042872165     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Malherbe WD: The manifestations and diagnosis of Babesia infections. Ann NY Acad Sci 64:128-146, 1956.
2. Breitschwerdt EB: Babesiosis, in Greene CG (ed): Infectious Diseases of the Dog and Cat. Philadelphia, WB Saunders Co, 1990, pp 796-803.
3. Taboada J, Merchant SR: Babesiosis of companion animals and man. Vet Clin North Am Small Anim Pract 21:103-123, 1991.
4. Maegraith B, Gilles HM, Devakul K: Pathological processes in Babesia canis infections. Zeits Topmed Parasit 8:485-514, 1957.
5. Uilenberg G, Franssen FFJ, Perie NM, et al: Three groups of Babesia canis distinguished and a proposal for nomenclature. Vet Q 11:33-40, 1989.
6. Van Zyl M: An analysis of hospitalised cases of canine babesiosis. Proc 19th World Small Anim Vet Assoc Cong:778, 1994.
7. Shakespeare AS: The incidence of canine babesiosis amongst sick dogs presented to the Onderstepoort Veterinary Academic Hospital. J S Afr Vet Assoc 66:247-250, 1995.
8. Littman MP: Clinical babesiosis in 26 dogs from Pennsylvania and New Jersey. Proc 9th Am College Vet Intern Med Forum:893, 1991.
9. Taboada J, Harvey JW, Levy MG, et al: Seroprevalence of babesiosis in greyhounds in Florida. JAVMA 200:47-50, 1992.
10. Yamane I, Gardner IA, Ryan CP, et al: Serosurvey of Babesia canis, Babesia gibsoni, and Ehrlichia canis in pound dogs in California, USA. Prevent Vet Med 18:293-304, 1994.
11. Jacobson LJ, Clark I: The pathophysiology of canine babesiosis: New approaches to an old puzzle. J S Afr Vet Assoc 65: 134-145, 1994.
12. Button C: Metabolic and electrolyte disturbances in acute canine babesiosis. JAVMA 175:475-479, 1979.
13. Taylor JH, Guthrie AJ, van der Walt JG, et al: The effect of Babesia canis induced haemolysis on the canine haemoglobin oxygen dissociation curve. J S Afr Vet Assoc 64:141-143, 1993.
14. Purvis D, Kirby R: Systemic inflammatory response syndrome: Septic shock. Vet Clin North Am Small Anim Pract 24:1225-1247, 1994.
15. Lichtman AR, Mohrcken S, Engelbrecht M, et al: Pathophysiology of severe forms of falciparum malaria. Crit Care Med 18:666-668, 1990.
16. Bland-van den Berg P: Management of Babesia canis infection and its complications. Proc Premiéres Recontres Vétérinaires Internationales du Limousin:9-26, 1992.
17. Moore DJ, Williams MC: Disseminated intravascular coagulation: A complication of Babesia canis infection in the dog. J S Afr Vet Assoc 50:265-275, 1979.
18. Cipolle MD, Pasquale MD, Cerra FB: Secondary organ dysfunction: From clinical perspectives to molecular mediators. Crit Care Clin 9:261-298, 1993.
19. Chew DJ, DiBartola SP: Diagnosis and pathophysiology of renal disease, in Ettinger SJ (ed): Textbook of Veterinary Internal Medicine. Philadelphia, WB Saunders Co, 1989, pp 1893-1961.
20. Clark IA, Rockett KA, Cowden WB: TNF in malaria, in Beutler B (ed): Tumor Necrosis: Factors, the Molecules and their Emerging Role in Medicine. New York, Raven Press, 1992, pp 303-328.
21. Stappendel RJ: Disseminated intravascular coagulation, in Kirk RW (ed): Current Veterinary Therapy. X. Philadelphia, WB Saunders Co, 1989, pp 451-457.
22. Button C: Fluid therapy in canine babesiosis. J S Afr Vet Assoc 47:281-287, 1976.
23. Leisewitz AL, Guthrie AJ, Berry WL: Evaluation of the effect of whole-blood transfusion on the oxygen status and acid-base balance of Babesia canis infected dogs using the oxygen status algorithm. J S Afr Vet Assoc 67:20-26, 1996.
24. Van Pelt DR, Wheeler SL, Wingfield WE: The use of bicarbonate in cardiopulmonary resuscitation. Campend Contin Educ Pract Vet 12:1393-1399, 1990.
25. Malherbe WD, Parkin BS: Atypical symptomatology in Babesia canis infection. J S Afr Vet Med Assoc 22:25-61, 1951.
26. Pagés JP, Trouillet JL: Lésions retiennes dans la babesiose du chien: a propos de 10 observations. Prat Méd Chir Anim Compag 21:389-397, 1984.
27. Carlotti DN, Pages JP Sorlin M: Skin lesions in canine babesiosis, in Ihrke PJ, Mason IS, White SD (eds): Advances in Veterinary Dermatology, vol 2. Oxford, Pergamon Press, 1992, pp 229-238.
28. Malherbe WD: Clinico-pathological studies of Babesia canis infection in dogs. V: The influence of the infection on kidney function. J S Afr Vet Med Assoc 37:261-264, 1965.
29. Reyers F: Is the azotaemia in canine babesiosis an indication of renal disease? in Proceedings of the 9th Faculty Day. Pretoria, South Africa, Faculty of Veterinary Science, University of Pretoria, 1992, p 17.
30. Okoh AEJ: A case of cerebral babesiosis in the dog. Bull Anim Health Product Afr 26:2-3, 1978.
31. Pages JP, Vidor E, Trouillet JL, et al: Description clinique, hematologique et serologique de 133 cas de babesiose canine. Prat Méd Chir Anim Compag 25:89-97, 1990.
32. Carlos ET, Radelad ER, Manzon JC: Haematological studies of clinical cases of canine babesiosis. Philippine J Vet Med 26:29-36, 1989.
33. Abdullahi SG, Mohammed AA, Trimnell AR, et al: Clinical and haematological findings in 70 naturally occurring cases of canine babesiosis. J Small Anim Pract 31:145-147, 1990.
34. Reyers F, Van Zyl M: Haematology of South African canine babesiosis. Proc Canine Babesiosis Symp:52-58, 1995.
35. Malherbe WD: Clinico-pathological studies of Babesia canis infection on bromsulphalein retention in the blood. J S Afr Vet Med Assoc 36:25-29, 1965.
36. Malherbe WD: Clinico-pathological studies of Babesia canis infection in dogs. II: The influence of the infection on plasma transaminase activity. J S Afr Vet Med Assoc 36:173-176, 1965.
37. Gilles HM, Maegraith BG, Andrews WHH: The liver in Babesia canis infection. Ann Trop Med Parasitol 47:426-430, 1953.
38. Thompson JP: Immunologic diseases, in Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine. Philadelphia, WB Saunders Co, 1995, pp 2002-2029.
39. Cotter SM: Autoimmune hemolytic anaemia in dogs. Compend Contin Educ Pract Vet 14:53-59, 1992.
40. Frevert CW, Warner AE: Respiratory distress resulting from acute lung injury in the veterinary patient. J Vet Intern Med 6:154-165, 1992.
41. Frostell CG: Lung permeability and other pathophysiological lung problems in shock. Act Anaesth Scand [37 Suppl] 98:11-13, 1993.
42. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455, 1992.
43. Freeman MJ, Kirby BM, Panciera DL, et al: Hypotensive shock syndrome associated with acute Babesia canis infection in a dog. JAVMA 204:94-96, 1994.
44. Lobetti RG: Leukaemoid response in two dogs with Babesia canis infection. J S Afr Vet Assoc 66:182-184, 1995.
45. Autran de Morais HS, DiBartola SP: Mixed acid-base disorders. Part I. Clinical approach. Compend Contin Educ Pract Vet 12:1619-1625, 1993.
46. Levy MG, Breitschwerdt EB, Moncol DJ: Antibody activity to Babesia canis in dogs in North Carolina. Am J Vet Res 48:339-341, 1987.
47. Jacobson LS, Reyers F, Berry WL, et al: Changes in haematocrit after treatment of uncomplicated canine babesiosis: A comparison between diminazene and trypan blue, and an evaluation of the influence of parasitaemia. J S Afr Vet Assoc 67:77-82, 1996.
48. Moore DJ: Therapeutic implications of Babesia canis infection in dogs. J S Afr Vet Assoc 50:346-352, 1979.
49. Swan GE: Antibabesial drugs for use in dogs and cats. Proc Canine Babesiosis Symp:64-68,1995.
50. McDougald LR, Roberson EL: Antiprotozoan drugs, in Booth NH, McDonald LE (eds): Veterinary Pharmacology and Therapeutics. Cedar Rapids, IA, Iowa State University Press, 1988, pp 950-968.
51. Milner RJ, Reyers F, Taylor JH, et al: The effect of diminazene aceturate on cholinesterase activity in dogs with canine babesiosis. J S Afr Vet Assoc 68:111-113, 1997.
52. Naude TW, Basson PA, Pienaar, JG: Experimental diamidine poisoning due to commonly used babecides. Onderstepoort J Vet Res 37:173-184, 1970.
53. Adeyanju BJ, Aliu YO: Chemotherapy of canine ehrlichiosis and babesiosis with imidocarb dipropionate. JAAHA 18: 827-830, 1982.
54. Jacobson LS, Lewis DC: Blood transfusion in dogs, with special reference to babesiosis. S Afr Vet Med 7:81-88, 1994.
55. Le Roux P: Blood transfusion in dogs and its effect in canine babesiosis. J S Afr Vet Assoc 36:21-22, 1965.
56. Cotter SM: Clinical transfusion medicine. Adv Vet Sci Comp Med 36:188-223, 1991.
57. Authement JM, Wolfsheimer KJ, Catching S: Canine blood component therapy: Product preparation, storage, and administration. JAAHA 23:483-493, 1987.
58. Lane IF, Grauer GF, Fettmen MJ: Acute renal failure. Part II: Diagnosis, management and prognosis. Campend Contin Educ Pract Vet 16:625-645, 1994.
59. Low DG, Cowgill LD: Emergency management of the acute uremic crisis, in Kirk RW (ed): Current Veterinary Therapy. IX. Philadelphia, WB Saunders Co, 1986, pp 981-989.
60. Weiser MG: Erythrocytes responses and disorders, in Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine. Philadelphia, WB Saunders Co, 1995, pp 1864-1891.
61. Merk SM: Drugs used for disorders of coagulation. Vet Clin North Am Small Anim Pract 18:1217-1241, 1988.
62. Stone MS, Cotter SM: Practical guidelines for transfusion therapy, in Kirk RW, Bonagura JD (eds): Current Veterinary Therapy. XI. Philadelphia, WB Saunders Co, 1992, pp 475-479.
63. Johnson SE: Acute hepatic failure, in Kirk RW (ed): Current Veterinary Therapy. X. Philadelphia, WB Saunders Co, 1989, pp 945-952.
64. Haskins SC: Management of septic shock. JAVMA 200: 1915-1924, 1992.
65. Miller MW, Schertel ER, DiBartola SP: Conventional and hypertonic fluid therapy, in Murtaugh RJ, Kaplan PM (eds): Veterinary Emergency and Critical Care Medicine. St Louis, Mosby Year Book, 1992, pp 618-628.
66. Court HM, Dodman NH, Seeler DC: Inhalation therapy. Oxygen administration, humidification and aerosol therapy. Vet Clin North Am Small Anim Pract 15:1041-1059, 1985.
67. Crowe DT: Managing respiration in the critical patient. Vet Med 84:55-76, 1989.
68. Curtis SE, Peek JT, Kelly DR: Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Phys 75:2696-2702, 1993.
69. Berry WL: Supportive therapy in canine babesiosis. Proc Canine Babesiosis Symp:83-88, 1995.
70. Moreau Y, Vidor E, Bussial G, et al: Vaccination against canine babesiosis: An overview of field observations. Trans Royal Soc Trop Med Hyg 83:95-96, 1989.
71. Lewis BD, Penzhorn BL, Lopez-Rebollar LM: Immune responses to South African Babesia canis and the development of a preliminary vaccine. J S Afr Vet Assoc 66:61-65, 1995.
72. Penzhorn BL, Lewis BD, de Waal DT, et al: Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene. J S Afr Vet Assoc 66:157-159, 1995.
73. Bigalke RD: Relapses and immunity in canine babesiosis. J S Afr Vet Assoc 47: 281-287, 1976.